| Literature DB >> 28892296 |
Cecilia Sahlgren1,2,3, Annika Meinander1, Hongbo Zhang4, Fang Cheng1, Maren Preis4, Chunlin Xu5, Tiina A Salminen6, Diana Toivola1,7, Daniel Abankwa3, Ari Rosling8, Didem Şen Karaman4, Outi M H Salo-Ahen4,6, Ronald Österbacka9, John E Eriksson1,2, Stefan Willför5, Ion Petre10, Jouko Peltonen11, Reko Leino12, Mark Johnson6, Jessica Rosenholm4, Niklas Sandler4.
Abstract
Approaches to increase the efficiency in developing drugs and diagnostics tools, including new drug delivery and diagnostic technologies, are needed for improved diagnosis and treatment of major diseases and health problems such as cancer, inflammatory diseases, chronic wounds, and antibiotic resistance. Development within several areas of research ranging from computational sciences, material sciences, bioengineering to biomedical sciences and bioimaging is needed to realize innovative drug development and diagnostic (DDD) approaches. Here, an overview of recent progresses within key areas that can provide customizable solutions to improve processes and the approaches taken within DDD is provided. Due to the broadness of the area, unfortunately all relevant aspects such as pharmacokinetics of bioactive molecules and delivery systems cannot be covered. Tailored approaches within (i) bioinformatics and computer-aided drug design, (ii) nanotechnology, (iii) novel materials and technologies for drug delivery and diagnostic systems, and (iv) disease models to predict safety and efficacy of medicines under development are focused on. Current developments and challenges ahead are discussed. The broad scope reflects the multidisciplinary nature of the field of DDD and aims to highlight the convergence of biological, pharmaceutical, and medical disciplines needed to meet the societal challenges of the 21st century.Entities:
Keywords: biological model systems; computational approaches; drug development; nanotechnology; tailored technologies and materials
Mesh:
Substances:
Year: 2017 PMID: 28892296 DOI: 10.1002/adhm.201700258
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933